Join
Live feed
·
PRReleasevia Quantisnow
PolyPid Ltd. logo

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
PYPD· PolyPid Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PYPD (PolyPid Ltd.) and more on Quantisnow.